Virulizin
Term · Oncology and biomedicine · MLC-T-ONC-009261
A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.
A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation.
| Identifier | MLC-T-ONC-009261 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | VIRU |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009261",
"term": "Virulizin",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.",
"A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation."
],
"abbreviation": "VIRU",
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/virulizin/"
}
Record 17,261 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.